WATERTOWN, Mass, April 15, 2024 – In light of the alarming dengue outbreak across South America, Exergen Corporation, a leading innovator in medical thermometry, is committed to aiding in the battle against this pervasive illness. With hundreds of thousands affected and a rising death toll in countries like Argentina and Brazil, the importance of vigilant health monitoring has never been more critical. Exergen is at the forefront, advocating for the essential role of fever detection in identifying and managing dengue.  

“Exergen Corporation stands with South America in these trying times, emphasizing the power of informed health monitoring in the fight against dengue,” says Dr Francsesco Pompei, founder and CEO Of Exergen Corporation. “Together, we can make a difference”.  

Understanding Dengue and the Critical Role of Fever Detection  

Dengue fever, a mosquito-borne disease, manifests through symptoms such as high fever, severe headaches, and muscle pain, escalating to more severe forms if not timely addressed. Fever, a primary indicator of dengue, serves as a crucial signal for potential infection and the need for immediate medical attention.  

Exergen’s Commitment: Equipping the Public and Medical Professionals  

Exergen Corporation is dedicated to providing effective solutions for fever monitoring, crucial in the early detection and intervention of dengue. Recognizing the urgency of the situation, Exergen is taking proactive steps to ensure that both the general public and healthcare providers in affected regions have access to the Exergen Temporal Artery Thermometer – a pinnacle of thermometry accuracy and ease of use.  

The Exergen Temporal Artery Thermometer: Precision and Ease of Use in Health Monitoring  

In the current dengue crisis, the Exergen Temporal Artery Thermometer is an indispensable tool for medical professionals and the general public alike. Its non-intrusive, swift, and accurate temperature measurements make it ideal for both home and clinical settings, ensuring that individuals and healthcare professionals can monitor temperatures effectively and efficiently.  

A Call to Action: Stay Informed, Stay Prepared  

Exergen Corporation urges everyone in the affected regions to remain vigilant and proactive in monitoring body temperature. Early detection of fever can significantly alter the course of dengue, leading to timely medical care and reducing the risk of severe outcomes.  

About Exergen
Exergen Corporation, the leader in non-invasive temperature measurement technologies for industrial and medical applications, delivers non-invasive temperature meters with higher accuracy, lower costs, less process control, and higher reliability than previously possible. Known in both healthcare and consumer markets for its award-winning arterial thermometer, Exergen was founded by MIT-educated and Harvard researcher Dr. Francesco Pompei, who holds more than 100 patents. Exergen Corporation is headquartered in Watertown, Massachusetts, United States.  

For media inquiries, please contact:
Christina Guilbert
cguilbert@exergen.com
www.exergen.com 

EXERGEN P/N: 850138, Rev 1